Endonetriyum kanseri

Cards (30)

  • Semptomlar:
  • Vajinal kanama (%90)
  • Pürülan Vajinal Akıntı (Kötü prognoz belirtisi)
  • Pelvik ağrı, bası ve rahatsızlık hissi
  • Asemptomatik (<%5)
  • Postmenopozal vajinal kanaması olan hastada endometrium kanseri olarak ele alınmalıdır, aksı ispat edilene kadar
  • Öncesi Değerlendirme
  • Tanı ve Tedavi:
  • Cerrahi evreleme yapılır
  • Tedavi:
  • Primer tedavi cerrahidir
  • Histerektomi + bilateral salpingo-ooferektomi ve gerektiğinde lenf nodu (pelvik-paraaortik) disseksiyonu + omentektomi
  • Erken evrede Total Abdominal Histerektomi + BSO yeterlidir (Evre IA)
  • Adjuvan tedavi seçenekleri:
  • Radyoterapi
  • Kemoterapi
  • Kemoradyoterapi
  • Prognostik faktörler
  • Risk factors include age, obesity, diabetes, hypertension, polycystic ovary syndrome (PCOS), tamoxifen use, nulliparity, early menarche, late menopause, estrogen-only HRT, and genetic predisposition.
  • The incidence of endometrial carcinoma has increased over time due to changes in lifestyle habits such as obesity, hormone replacement therapy (HRT), and dietary factors.
  • Endometrial cancer is the most common gynecological malignancy, accounting for approximately 30% of all cancers of the female reproductive system.
  • Most patients present with localized disease that has not spread beyond the uterus.
  • Endometrial cancer is the most common gynecologic malignancy with an increasing incidence rate over time.
  • In Turkey, it ranks second among gynecological tumors after cervical cancer.
  • Approximately 15% of cases are diagnosed at an advanced stage when the tumor has invaded adjacent organs or metastasized to distant sites.
  • There are two types of endometrial cancer: Type I (endometroid) and Type II (non-endometroid).
  • The majority of endometrial cancers are diagnosed at an early stage due to symptoms such as abnormal vaginal bleeding or discharge.
  • Approximately 60% of patients are diagnosed at stage I, which means they have only localized disease within the uterus.
  • Risk factors for endometrial cancer include unopposed estrogen exposure, tamoxifen use, genetic predisposition, and Lynch syndrome.
  • Type I endometrial carcinoma accounts for about 80% of all cases and includes endometrioid adenocarcinomas, serous papillary carcinomas, clear cell carcinomas, and mixed epithelial/stromal tumors.